Baker Lab: Neutralizing Snake Venom with AI-Designed Miniproteins
Researchers from the Baker Lab at the University of Washington, in collaboration with the Digital Biotechnology Lab at the Technical …
All Posts
Recursion and Faro Health Partner to Reimagine Clinical Trial Design with AI
Faro Health has partnered with Recursion to streamline clinical protocol design using Faro's AI-driven platform.
Servier, Google Cloud Extend Partnership to Accelerate Drug Development with AI
Servier, an international pharmaceutical group, and Google Cloud have announced a five-year extension of their collaboration to integrate AI technologies …
Lupa Raises $4M to Modernize Veterinary Care with AI
Lupa, a London-based startup developing an AI-powered veterinary operating system, has raised $4 million in seed funding from investors including …
Proscia Grows with 2.4 Million Patients Diagnosed via AI Pathology Platform
Proscia, a company specializing in AI-enabled pathology solutions, reported significant growth in 2024, driven by an increasing demand for enterprise …
AI-Driven Analysis Optimizes Clinical Strategy for A28’s Liver Cancer Peptide Therapy
A28 Therapeutics, a clinical-stage biopharmaceutical company, and GATC Health Corp, a developer of AI-driven drug discovery tools, have announced the …
Umoja Secures $100M For In Vivo CAR-T Therapies
Umoja Biopharma has secured $100 million in an oversubscribed Series C funding round. Based in Seattle, Washington, and founded in …
Eli Lilly Acquires Scorpion Therapeutics' Oncology Program for $2.5 Billion
Eli Lilly announced the acquisition of Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program for up to $2.5 billion, expanding its oncology …
Vevo Therapeutics Plans to Open Source 100M Single-Cell Atlas for Drug Discovery
Vevo Therapeutics has announced plans to open source its Tahoe-100M dataset, described as the world's largest single-cell transcriptomic atlas of …
Bioptimus Reaches $76M Milestone as It Prepares for Next-Gen AI Foundation Model
Bioptimus, a French AI startup, has announced a $76 million funding milestone, with $41 million secured in its latest round …
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
AbCellera has announced an expansion of its collaboration with AbbVie to include the development of T-cell engagers (TCEs) for oncology, …
AbbVie Partners with Simcere on T-Cell Engager for Multiple Myeloma in $1B Deal
AbbVie has partnered with Simcere Zaiming, a subsidiary of Simcere Pharmaceutical, to advance a trispecific antibody candidate, SIM0500, for relapsed …